Arthec S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-04-30
Share capital
125,057.10 PLN
Activity description

Arthec is a company that develops the Pearl method, a tissue-engineered solution for osteoarthritis that aims to regenerate cartilage and restore joint function without the need for invasive joint replacement surgery. The method utilizes proprietary technology to create structured cartilage tissue that mimics the properties of native cartilage, ensuring natural integration within the joint. Arthec's approach focuses on reducing invasiveness and promoting faster recovery for patients with early to moderate cartilage lesions.

Registered address
ul. Starodworska 1, 80-137 Gdańsk, Poland
Website
Email
Social media
Electronic delivery address
AE:PL-74927-84632-ASJBI-33

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

Financial statements were filed on time, on average 22 days early. All were audited by a statutory auditor.

  • 202517/06/2026
  • 202430/06/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Scientific research and development1,398 / 1,942
Top 72%
City · Gdańsk6,409 / 7,519
Top 85%
Voivodeship · Pomorskie17,541 / 20,095
Top 87%
Country · Poland258,996 / 298,026
Top 87%

Results vs industry

Revenue
This companyUSD 10.91kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -612.94kMedianUSD -1.27kAverageUSD -92.87k
Operating costs
This companyUSD 623.61kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 1.07mMedianUSD 134.71kAverageUSD 3.04m

Offer

  • Joint regeneration devices
  • Osteoarthritis treatment method
  • Clinical trials
  • Medical solutions
Certifications: ISO 13485

Websites

  • arthec.euArThec – Pearl
    WordPress 4.2ElementorGoogle AnalyticsGoogle Tag ManagerNginx

Authorized Representatives

Sławomir Jaros age 46 – Management Board Member
Marek Putko age 59 – President of the Management Board

Manner of representation

In the case of a one-person management board, the sole member of the management board is authorised to submit declarations of will concerning the rights and obligations on behalf of the company. In the case of the appointment of a multi-member management board, joint action by two members of the management board acting jointly is required to submit declarations of will concerning the rights and obligations on behalf of the company.

Supervisory board

Paweł Piotr Błachno age 51 – Supervisory Board Member
Tomasz Brzostowski age 49 – Supervisory Board Member
Grzegorz Zbigniew Sobieraj age 47 – Supervisory Board Member
Henryk Jaros age 72 – Supervisory Board Member
Katarzyna Łukaszewicz age 32 – Supervisory Board Member

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2019-09-04.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Apr 25, 2025Bankruptcy notice
Apr 25, 2025Call to heirs

Public aid

PurposeGross amount
Aid for research and development projects: experimental development
$3.5M
Aid for research and development projects: industrial research
$1.5M
Aid for SME access to finance — aid for start-ups
$219.1K

European Funds

ProjectEU co-financing
PEARL method – in vitro production of fully functional autologous hyaline cartilage ready for implementation, which biologically restores joint function
$4.6M

Competitors

Name
Fly-Gen sp. z o.o.
Orphinic Scientific S.A.
Biolabic sp. z o.o.
DR Joanna Sanford sp. k.
Air Abrasion System sp. z o.o.
Bonereg sp. z o.o.
Thesybin Labs P.S.A.
Bioinfo Capital sp. z o.o.
Jotachem sp. z o.o.
Poltiss sp. z o.o.

Change history

DateEvent
2025-04-01Share capital increase
2024-04-30Entered in the register

FAQ

Last updated: 2026-06-22